Dengue fever now threatens half of the world’s population, but small molecule treatments could be an answer to treating the .

Research and Development (R&D) Expenses: R&D expenses decreased to $5.8 million for the three months ended March 31, 2025, ...

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...

An advocate for cancer patients has said that patients will "die waiting" for cancer treatments in Ireland after a study ...

Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...

The FDA has communicated to Stealth BioTherapeutics that it would not meet elamipretide’s PDUFA target date for the treatment of Barth syndrome.

The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...

The product, available in 200 mg, 400 mg, 600 mg, and 800 mg strengths, is the generic equivalent of Sumitomo Pharma ...

Global agencies have collaborated to create parallel regulatory approval solutions to help get drugs to patients more quickly ...

There are 21 applicants to become the city of New Bedford’s next chief of police. Here's the process of what happens next.

The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.